StockComparison Logo
vs

IBN vs GSK

Comparison between ICICI Bank Ltd (IBN, Company) and GSK Plc (GSK, Company).

IBN is from the Financial Services sector, while GSK is from the Healthcare sector.

5-Year PerformanceIBN has outperformed GSK, delivering a return of +12.0% compared to +5.5%

IBN vs GSK - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
IBN
$105B
GSK
$105B
Max Drawdown
IBN
86.33%
Winner
GSK
64.03%
Sharpe Ratio
IBN
-0.66
Winner
GSK
1.31
5Y Beta
IBN
0.41
Winner
GSK
0.22
Industry
IBN
Banks - Regional
GSK
Drug Manufacturers - General
P/E Ratio
IBN
17.29
Winner
GSK
12.08
Forward P/E
Winner
IBN
17.36
GSK
21.51
PEG Ratio
IBN
0.53
Winner
GSK
0.10
Dividend Yield
IBN
0.86%
Winner
GSK
3.51%
5Y Dividends CAGR
IBN
N/A
GSK
1.34%
5Y EPS CAGR
Winner
IBN
18.19%
GSK
4.65%
Debt to Equity
IBN
N/A
GSK
106.74%
Free Cash Flow Yield
IBN
-2.08%
Winner
GSK
8.05%
P/S Ratio
Winner
IBN
0.05
GSK
3.13
P/B Ratio
Winner
IBN
2.70
GSK
4.36

IBN vs GSK - Historical Returns

Returns include dividend reinvestment.

1M
Winner
IBN
+16.67%
GSK
+9.53%
3M
Winner
IBN
+15.17%
GSK
-4.57%
6M
IBN
-1.65%
Winner
GSK
+9.90%
1Y
IBN
-11.49%
Winner
GSK
+44.44%
5Y(CAGR)
Winner
IBN
+12.03%
GSK
+5.46%
10Y(CAGR)
Winner
IBN
+16.76%
GSK
+4.70%
Max(CAGR)
Winner
IBN
+11.21%
GSK
+3.27%

IBN vs GSK - Annual Returns (1999 - 2026)

Returns include dividend reinvestment.

YearIBNGSK
2026-1.65%+9.90%
2025+0.73%+50.62%
2024+28.43%-6.27%
2023+9.55%+9.25%
2022+8.20%-32.73%
2021+37.45%+23.62%
2020-2.43%-17.52%
2019+44.62%+30.36%
2018+4.75%+9.29%
2017+43.94%-3.80%
2016+0.11%+1.52%
2015-33.23%+0.48%
2014+62.86%-14.73%
2013-17.14%+26.97%
2012+58.07%-0.75%
2011-47.59%+22.51%
2010+34.57%-3.72%
2009+85.60%+20.27%
2008-68.46%-21.93%
2007+47.15%-2.77%
2006+41.97%+6.93%
2005+47.93%+9.96%
2004+12.83%+5.08%
2003+178.06%+25.04%
2002+41.63%-22.83%
2001-23.81%-9.58%
2000-55.26%+5.67%
1999N/A-5.78%

IBN vs GSK Drawdown Comparison

The maximum drawdown for IBN was -86.08%, occurring on Mar 9, 2009. Recovery took 1772 trading sessions.

The maximum drawdown for GSK was -50.11%, occurring on Sep 27, 2022. Recovery took 935 trading sessions.

The current IBN drawdown is -13.63%. The current GSK drawdown is -10.85%.

RankIBNGSK
#1-86.08%
Jan 10, 2008 - Jan 26, 2015
-50.11%
Apr 13, 2022 - Jan 6, 2026
#2-84.49%
Apr 7, 2000 - Dec 29, 2003
-49.64%
Apr 20, 2007 - Apr 18, 2012
#3-58.79%
Jan 27, 2015 - Jan 25, 2018
-45.23%
Apr 25, 2000 - Nov 11, 2005
#4-55.05%
Feb 12, 2020 - Feb 1, 2021
-32.56%
Jan 17, 2020 - Dec 10, 2021
#5-38.62%
Jan 2, 2004 - Nov 23, 2004
-27.97%
Mar 4, 2014 - Sep 3, 2019
#6-33.10%
Mar 1, 2006 - Oct 12, 2006
-26.98%
Nov 5, 1999 - Apr 11, 2000
#7-31.19%
Jan 26, 2018 - Mar 15, 2019
-18.61%
Feb 18, 2026 - Jun 2, 2026
#8-28.56%
Jul 19, 2007 - Oct 1, 2007
-14.45%
Jan 18, 2022 - Apr 7, 2022
#9-26.24%
Jan 12, 2022 - Aug 12, 2022
-10.52%
May 16, 2006 - Feb 13, 2007
#10-26.21%
Jul 23, 2025 - Mar 30, 2026
-10.48%
Oct 4, 2012 - Mar 22, 2013
#11-21.98%
Sep 30, 2005 - Dec 16, 2005
-8.45%
May 28, 2013 - Nov 1, 2013
#12-21.84%
Feb 8, 2007 - May 16, 2007
-8.43%
Apr 11, 2000 - Apr 25, 2000
#13-20.70%
Feb 16, 2021 - May 27, 2021
-8.16%
Nov 11, 2005 - Mar 8, 2006
#14-20.38%
Oct 31, 2007 - Jan 10, 2008
-7.54%
Feb 14, 2007 - Apr 16, 2007
#15-20.18%
Feb 28, 2005 - Jul 5, 2005
-7.37%
Jan 21, 2014 - Feb 13, 2014

Correlation

Correlation between IBN and GSK is 0.73 which considered as a strong positive correlation - the stocks tend to move together.

0.73
-101

Dividend Comparison (2000 - 2026)

IBN vs GSK dividend yield comparison.

YearIBNGSK
20260.00%1.65%
20250.84%3.42%
20240.80%4.60%
20230.81%3.75%
20220.57%5.47%
20210.27%4.99%
20200.00%5.59%
20190.19%4.35%
20180.43%5.65%
20170.79%5.83%
20161.98%6.86%
20154.01%5.93%
20141.32%6.20%
20131.79%4.51%
20121.32%5.70%
20112.35%4.83%
20102.07%5.10%
20091.22%4.39%
20082.68%5.74%
20070.81%4.09%
20060.87%3.29%
20051.35%3.03%
20041.62%3.38%
20031.90%2.77%
20021.26%3.10%
20011.79%1.54%
20000.00%4.57%

Select Stocks to Compare